• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Basic Medical Sciences
      • Volume 22, Issue 1
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Basic Medical Sciences
      • Volume 22, Issue 1
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Computational and pharmacological investigation of novel 1,5-diaryl-1,4-pentadien-3-one derivatives for analgesic, anti-inflammatory and anticancer potential

      (ندگان)پدیدآور
      Tariq, Muhammad SherazKhan, Arif-ullahMinhas, Amber MahmoodFilho, Edson RodriguesDin, Zia udKhan, Asalm
      Thumbnail
      دریافت مدرک مشاهده
      FullText
      اندازه فایل: 
      772.4کیلوبایت
      نوع فايل (MIME): 
      PDF
      نوع مدرک
      Text
      Original Article
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Objective(s): The novel 1,5-diaryl-1,4-pentadien-3-one derivatives were studied for analgesic, anti-inflammatory and anticancer potential to establish their role in pain, inflammatory disorders and cancer.Materials and Methods: Two 1,5- diaryl-1,4-pentadien-3-one derivatives: (1E,4E)- 5-(4-fluoro phenyl)-1-(4-methoxyphenyl)- 2-methylpenta-1,4-dien-3-one (A2K2A17) and  (1E,4E)-5-(4-nitrophenyl)-1-(4-nitrophenyl)-2-ethylhexa-1,4-dien-3-one (A11K3A11) were synthesized and characterized via 1H NMR and 13C NMR techniques. Molecular docking, anti-inflammatory, analgesic and anticancer activities were performed using Auto Doc Vina, carrageenan mediated paw edema and formalin induced chronic inflammation, acetic acid induced writhings and hotplate assay and brine-shrimp lethality assay. Results: A2K2A17 and A11K3A11 showed high computational affinities (binding energy > -9.0 Kcal/mol) against COX-1, kappa receptor and braf kinase domain. A2K2A17 and A11K3A11 exhibited moderate docking affinities (binding energy > -8.0 Kcal/mol) against COX-2, human capsaicin receptor, tumor necrosis factor, lipoxygenase, colony stimulating factor, delta receptor, cyclin dependent protein kinase-2, mitogen activated kinase, mu receptor and kit kinase domain. A2K2A17 and A11K3A11 possess low docking affinities (binding energy > -7.0 Kcal/mol) against purinoceptor, platelets-derived growth Factor-1 and vascular-endothelial growth factor. In analgesic activity, A2K2A17 (1-30 mg/kg) and A11K3A11 (1-10 mg/kg) decreased acetic acid induced writhes and prolonged the latency time (P -9.0 Kcal/mol) against COX-1, kappa receptor and braf kinase domain. A2K2A17 and A11K3A11 exhibited moderate docking affinities (binding energy > -8.0 Kcal/mol) against COX-2, human capsaicin receptor, tumor necrosis factor, lipoxygenase, colony stimulating factor, delta receptor, cyclin dependent protein kinase-2, mitogen activated kinase, mu receptor and kit kinase domain. A2K2A17 and A11K3A11 possess low docking affinities (binding energy > -7.0 Kcal/mol) against purinoceptor, platelets-derived growth Factor-1 and vascular-endothelial growth factor. In analgesic activity, A2K2A17 (1-30 mg/kg) and A11K3A11 (1-10 mg/kg) decreased acetic acid induced writhes and prolonged the latency time (P -8.0 Kcal/mol) against COX-2, human capsaicin receptor, tumor necrosis factor, lipoxygenase, colony stimulating factor, delta receptor, cyclin dependent protein kinase-2, mitogen activated kinase, mu receptor and kit kinase domain. A2K2A17 and A11K3A11 possess low docking affinities (binding energy > -7.0 Kcal/mol) against purinoceptor, platelets-derived growth Factor-1 and vascular-endothelial growth factor. In analgesic activity, A2K2A17 (1-30 mg/kg) and A11K3A11 (1-10 mg/kg) decreased acetic acid induced writhes and prolonged the latency time (P -7.0 Kcal/mol) against purinoceptor, platelets-derived growth Factor-1 and vascular-endothelial growth factor. In analgesic activity, A2K2A17 (1-30 mg/kg) and A11K3A11 (1-10 mg/kg) decreased acetic acid induced writhes and prolonged the latency time (PConclusion: The in silico, in vitro and in vivo studies on A2K2A17 and A11K3A11 reports their computational binding affinities against targets as well as the analgesic, anti-inflammatory and the anticancer effects.
      کلید واژگان
      Analgesic
      Anticancer
      Anti-inflammatory
      In silico studies
      Mice
      Pharmaceutical Sciences

      شماره نشریه
      1
      تاریخ نشر
      2019-01-01
      1397-10-11
      ناشر
      Mashhad University of Medical Sciences
      سازمان پدید آورنده
      Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
      Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
      Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
      LaBioMMi, Department of Chemistry, Federal University of São Carlos, CP 676, 13.565-905, São Carlos, SP, Brazil
      LaBioMMi, Department of Chemistry, Federal University of São Carlos, CP 676, 13.565-905, São Carlos, SP, Brazil
      Basic Sciences Department, College of Science and Health Professions-(COSHP-J) King Saud bin Abdulaziz University for Health Sciences, Jeddah, Kingdom of Saudi Arabia

      شاپا
      2008-3866
      2008-3874
      URI
      https://dx.doi.org/10.22038/ijbms.2018.31261.7536
      http://ijbms.mums.ac.ir/article_11740.html
      https://iranjournals.nlai.ir/handle/123456789/339698

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب